Home › Moberg Pharma Announces Plans to Develop BUPI Through Phase III
 

Keywords :   


Moberg Pharma Announces Plans to Develop BUPI Through Phase III

2016-03-22 11:47:34| Appliances - Topix.net

The decision follows an evaluation of the complete data set from the recent phase II study for BUPI. BUPI is a patent pending lozenge formulation of bupivacaine for pain management in oral mucositis in cancer patients.

Tags: iii plans develop phase

Category:Consumer Goods and Services

Latest from this category

All news
23.11'Trust and reserve judgement' on rebrand, says Jaguar
23.11UK wants to hire EU negotiator to 'reset' relations
23.11Sisters build global beauty brand from a garage
23.11Versace bag for 15: Why Christmas shoppers are choosing charity shops
23.11'We are being robbed': Homeowners feel trapped by rising fees
22.11'Scammers sent courier to steal 4,000'
22.11Spain fines budget airlines including Ryanair 179m
22.11Formulating Biphasic and Triphasic Products
Consumer Goods and Services »
24.11Portrait.Of.Pirates ver2.5
24.11Switch
24.11 / TIN
24.11duranduranALMGHTY 26.5cm
24.11straykids skzoo
24.11 4
24.11 TrioTryiT Figure21
24.11
More »